drugset / Trial / NCT04708795

Clinical Trial on Pharmacokinetic and Tolerability of AP701

NCT04708795 ↗

Phase 1 Completed 15 enrolled CannaXan GmbH
NaSingle-groupOpen-labelOther

Summary

This study aims to investigate the uptake of AP701, a preparation from cannabis flowers, into the bloodstream after in single administration in healthy volunteers.

Timeline

Start
2020-01-11
Primary completion
2021-03-07
Completion
2021-03-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AP701 Unknown — Oral

Indications

No indication recorded.